A white blood cell count of 15.5 ×10⁹/L is mildly elevated but generally not concerning in a patient on ipratropium/albuterol and lorazepam, as neither medication typically causes clinically significant leukocytosis.
Clinical Context and Interpretation
This WBC count represents mild leukocytosis (normal range approximately 4-11 ×10⁹/L). The elevation is modest and requires clinical correlation rather than immediate alarm.
Medication Effects on WBC
Ipratropium/Albuterol (DuoNeb):
- Beta-agonists like albuterol can cause transient increases in WBC through neutrophil demargination
- Studies show nebulized albuterol produces minimal to no clinically significant WBC elevation in most patients 1
- One study found mean WBC increased only from 10.33 to 10.66 (×10³/μL) after albuterol nebulization 1
- Another study in healthy volunteers showed no significant WBC changes with nebulized albuterol 2
- Any effect is typically transient and resolves within hours
Lorazepam (Ativan):
- Benzodiazepines generally do not cause leukocytosis
- Some research suggests certain benzodiazepines may have immunomodulatory effects, but lorazepam specifically has not been shown to increase WBC 3
- The FDA label for lorazepam does not list leukocytosis as an adverse effect 4
Clinical Decision Algorithm
Step 1: Assess for infection or inflammation
- Check for fever (>38.3°C), hypothermia (<36°C), or tachycardia
- Look for localizing symptoms: cough, dysuria, wound changes, abdominal pain
- Examine for signs of pneumonia, urinary tract infection, or other infectious sources
Step 2: Evaluate the differential count
- If neutrophil predominance with left shift → suggests bacterial infection
- If lymphocyte predominance → consider viral infection or other causes
- If eosinophilia → consider allergic reaction or parasitic infection
Step 3: Consider timing relative to medication administration
- If WBC drawn within 1-2 hours of albuterol nebulization → may reflect transient demargination
- Repeat WBC in 6-12 hours if no clinical concern for infection
Step 4: Look for alternative explanations
- Physical or emotional stress
- Recent surgery or trauma
- Corticosteroid use (even inhaled steroids can increase WBC by 12-30%) 5
- Smoking
- Underlying inflammatory conditions
When to Investigate Further
Repeat CBC with differential if:
- Patient has fever, signs of infection, or clinical deterioration
- WBC continues to rise on serial measurements
- Absolute neutrophil count >20 ×10⁹/L
- Presence of immature forms (bands, metamyelocytes) suggesting left shift
Consider additional workup if:
- WBC persistently >15 ×10⁹/L without clear infectious source
- Patient appears septic (hypotension, altered mental status, organ dysfunction) 6
- Concern for pneumonia in hospitalized patient (WBC >12 ×10⁹/L is a risk factor) 7
Important Caveats
Do not confuse this with medication-induced leukopenia, which is the more serious concern with certain drugs. The guidelines you might encounter about WBC monitoring (such as those for clozapine requiring baseline WBC ≥3,500/mm³) 8 address the opposite problem—dangerously low WBC counts that can lead to agranulocytosis.
A WBC of 15.5 is NOT:
- Severe leukocytosis (which would be >25-30 ×10⁹/L)
- An indication to stop current medications
- Automatically indicative of serious infection
The key is clinical correlation: A patient with WBC 15.5 who is afebrile, hemodynamically stable, and without localizing symptoms likely needs only observation and possibly a repeat count. The same WBC in a febrile, tachycardic patient with respiratory symptoms warrants immediate investigation for pneumonia or other serious infection.